Exosome Diagnostics Lands $17,600,000 Series B Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4548458f-fd30-4e2b-8829-c41a2e5f6670 - Date
9/4/2015 - Company Name
Exosome Diagnostics - Mailing Address
840 Memorial Drive Cambridge, MA 02139 USA - Company Description
Exosome Diagnostics, Inc. is focused on commercializing minimally invasive molecular diagnostics using body fluids. - Website
http://www.exosomedx.com - Transaction Type
Venture Equity - Transaction Amount
$17,600,000 - Transaction Round
Series B - Proceeds Purposes
These funds also will enable us to drive our next generation of cancer diagnostics and, importantly, begin expanding into other disease areas, potentially bringing the benefits of exosome-based molecular diagnostics to patients across a broad spectrum of indications and medical needs. - M&A Terms
- Venture Investor
Forbion Capital Partners - Venture Investor
NGN Capital - Venture Investor
Arcus Ventures - Venture Investor
Tiger Global Management - Venture Investor
CD Ventures
